Variant report

Variant	rs11657423
Chromosome Location	chr17:17728574-17728575
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:26)
CpG islands
(count:0)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:26 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	NR2F2	chr17:17728400-17728794	K562	blood:	n/a	n/a
2	ELF1	chr17:17728452-17728703	K562	blood:	n/a	n/a
3	RXRA	chr17:17728099-17728674	HepG2	liver:	n/a	chr17:17728389-17728396 chr17:17728654-17728661
4	POLR2A	chr17:17728093-17728622	Hela-S3	cervix:	n/a	n/a
5	POLR2A	chr17:17723997-17728661	K562	blood:	n/a	n/a
6	POLR2A	chr17:17728408-17728645	H1-hESC	embryonic stem cell:	n/a	n/a
7	POLR2A	chr17:17726507-17728636	HepG2	liver:	n/a	n/a
8	EP300	chr17:17728395-17728639	K562	blood:	n/a	n/a
9	POLR2A	chr17:17728188-17728658	Hela-S3	cervix:	n/a	n/a
10	POLR2A	chr17:17728084-17728714	K562	blood:	n/a	n/a
11	TCF12	chr17:17727037-17729222	A549	lung:	n/a	n/a
12	POLR2A	chr17:17725297-17728677	K562	blood:	n/a	n/a
13	ZNF384	chr17:17728506-17729833	K562	blood:	n/a	n/a
14	MAZ	chr17:17728244-17728701	HepG2	liver:	n/a	n/a
15	NANOG	chr17:17728477-17728816	H1-hESC	embryonic stem cell:	n/a	n/a
16	MAX	chr17:17726456-17728739	HepG2	liver:	n/a	n/a
17	MAZ	chr17:17728085-17728801	K562	blood:	n/a	n/a
18	UBTF	chr17:17727168-17728582	K562	blood:	n/a	n/a
19	TFAP2C	chr17:17728387-17729465	Hela-S3	cervix:	n/a	n/a
20	MAZ	chr17:17728425-17728650	Hela-S3	cervix:	n/a	n/a
21	POLR2A	chr17:17728231-17728658	K562	blood:	n/a	n/a
22	CREB1	chr17:17726649-17728634	HepG2	liver:	n/a	n/a
23	POLR2A	chr17:17727193-17728669	K562	blood:	n/a	n/a
24	POLR2A	chr17:17728178-17728655	HepG2	liver:	n/a	n/a
25	MAX	chr17:17726306-17728751	A549	lung:	n/a	n/a
26	POLR2A	chr17:17728347-17728795	K562	blood:	n/a	n/a

No data

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:17727418..17729272-chr17:17876604..17878211,2	K562	blood:
2	chr17:17728072..17729601-chr17:17761601..17763775,2	K562	blood:
3	chr17:17583643..17586896-chr17:17724231..17729521,8	MCF-7	breast:
4	chr17:17587859..17589377-chr17:17727052..17729783,2	K562	blood:

No data

Variant related genes	Relation type
SREBF1	TF binding region
ENSG00000108557	Chromatin interaction

Extended variants
information (count: 148 )
Associated
traits (count: 3 )

rSNPs within LD-proxies of this variant (count:114)

rs_ID	r²[population]
rs10048206	0.85[GIH][hapmap];0.88[MEX][hapmap]
rs1052299	0.95[CEU][hapmap];1.00[CHB][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap];0.83[MEX][hapmap];0.91[TSI][hapmap];0.81[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs11078399	0.88[AMR][1000 genomes];0.95[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs11078400	0.86[CEU][hapmap];0.88[GIH][hapmap];0.87[MEX][hapmap];0.84[TSI][hapmap];0.86[EUR][1000 genomes]
rs11078406	0.85[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap]
rs11078408	0.80[MEX][hapmap]
rs1108648	0.94[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs11650649	1.00[CHB][hapmap];0.82[GIH][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap]
rs11652144	0.94[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs11652881	0.91[CEU][hapmap];1.00[JPT][hapmap];0.92[MEX][hapmap];0.80[TSI][hapmap];0.82[AMR][1000 genomes]
rs11654081	0.89[CEU][hapmap];0.84[JPT][hapmap]
rs11656665	0.95[CEU][hapmap];1.00[JPT][hapmap];0.95[AMR][1000 genomes];0.87[EUR][1000 genomes]
rs11657074	0.83[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs11657130	0.96[AMR][1000 genomes];0.96[EUR][1000 genomes];0.80[ASN][1000 genomes]
rs11658309	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes]
rs11870660	0.80[MEX][hapmap]
rs12450799	0.92[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs12936037	0.83[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs12936927	0.85[AMR][1000 genomes];0.86[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs12938501	0.86[AMR][1000 genomes];0.97[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs12941039	0.86[CEU][hapmap];1.00[CHB][hapmap];0.85[GIH][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap];0.83[TSI][hapmap];0.86[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs12943500	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs12946746	0.93[AMR][1000 genomes];0.96[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs12952723	0.85[AMR][1000 genomes];0.98[EUR][1000 genomes]
rs12953299	1.00[CHB][hapmap];0.87[CHD][hapmap];0.91[ASN][1000 genomes]
rs16960744	0.95[CEU][hapmap];0.91[GIH][hapmap];0.88[MEX][hapmap];0.93[TSI][hapmap];0.87[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs1889014	0.82[AMR][1000 genomes]
rs1889018	0.80[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];0.85[CHD][hapmap];0.97[GIH][hapmap];1.00[JPT][hapmap];0.91[MEX][hapmap];0.95[TSI][hapmap];0.96[AMR][1000 genomes];0.97[EUR][1000 genomes];0.80[ASN][1000 genomes]
rs2236513	0.95[CEU][hapmap];1.00[JPT][hapmap];0.84[AMR][1000 genomes];0.94[EUR][1000 genomes]
rs2297508	0.91[CEU][hapmap]
rs2350976	0.86[CEU][hapmap];1.00[JPT][hapmap];0.92[MEX][hapmap];0.80[TSI][hapmap];0.82[AMR][1000 genomes]
rs2350977	0.85[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap]
rs3183702	0.95[CEU][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];0.92[MEX][hapmap];0.91[TSI][hapmap];0.84[AMR][1000 genomes];0.94[EUR][1000 genomes]
rs34673242	0.86[YRI][hapmap]
rs35451946	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs3744113	0.80[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs3744115	0.91[CEU][hapmap];1.00[CHB][hapmap];0.91[GIH][hapmap];1.00[JPT][hapmap];0.83[MEX][hapmap];0.91[TSI][hapmap];0.81[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs3818717	0.82[CEU][hapmap];1.00[JPT][hapmap]
rs4244602	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs4257260	0.85[GIH][hapmap];0.88[MEX][hapmap]
rs4299203	0.80[MEX][hapmap]
rs4341796	1.00[CHB][hapmap];0.82[GIH][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap]
rs4413022	0.82[CEU][hapmap]
rs4459604	0.84[MEX][hapmap]
rs4470201	0.85[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap]
rs4584886	0.83[MEX][hapmap]
rs4924821	0.89[AMR][1000 genomes];0.85[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs4924822	0.91[CEU][hapmap];0.94[GIH][hapmap];1.00[JPT][hapmap];0.87[MEX][hapmap];0.95[TSI][hapmap];0.80[AMR][1000 genomes];0.94[EUR][1000 genomes]
rs4924823	0.86[CEU][hapmap];0.88[GIH][hapmap];0.88[MEX][hapmap];0.82[TSI][hapmap];0.85[EUR][1000 genomes]
rs4924832	0.80[MEX][hapmap]
rs4925114	0.91[CEU][hapmap];0.83[MEX][hapmap]
rs4925115	0.95[CEU][hapmap];0.86[TSI][hapmap];0.84[EUR][1000 genomes]
rs4925116	0.85[AMR][1000 genomes];0.98[EUR][1000 genomes]
rs4925119	0.95[CEU][hapmap];0.94[GIH][hapmap];0.92[MEX][hapmap];0.98[TSI][hapmap];0.85[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs4925120	0.95[CEU][hapmap];0.91[GIH][hapmap];0.88[MEX][hapmap];0.93[TSI][hapmap];0.85[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs4925123	1.00[CHB][hapmap];0.82[GIH][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap]
rs4925125	0.85[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap]
rs4925126	0.85[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap]
rs4925129	1.00[CHB][hapmap];0.82[GIH][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap]
rs4925130	1.00[CHB][hapmap];0.82[JPT][hapmap];0.83[MEX][hapmap]
rs5002487	1.00[CHB][hapmap];0.82[GIH][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap]
rs56248913	0.83[AMR][1000 genomes]
rs58638639	0.83[EUR][1000 genomes]
rs6502618	0.80[AMR][1000 genomes];0.87[EUR][1000 genomes]
rs6502619	1.00[CHB][hapmap];0.82[JPT][hapmap];0.81[AMR][1000 genomes]
rs6502622	0.85[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap]
rs6502624	0.85[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap]
rs6502625	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs6502629	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs6502632	0.80[MEX][hapmap]
rs7207395	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs7212167	0.80[MEX][hapmap]
rs7213225	0.85[GIH][hapmap];0.88[MEX][hapmap]
rs7214002	0.82[CEU][hapmap]
rs7219320	0.80[MEX][hapmap]
rs7222480	0.82[CEU][hapmap];1.00[CHB][hapmap];0.81[GIH][hapmap];0.87[MEX][hapmap]
rs7224815	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs7359509	0.81[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];0.85[CHD][hapmap];0.97[GIH][hapmap];1.00[JPT][hapmap];0.91[MEX][hapmap];0.95[TSI][hapmap];0.93[AMR][1000 genomes];0.96[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs7501812	0.91[CEU][hapmap];1.00[CHB][hapmap];0.88[GIH][hapmap];1.00[JPT][hapmap];0.91[MEX][hapmap];0.87[TSI][hapmap];0.82[AMR][1000 genomes];0.91[EUR][1000 genomes]
rs7503334	1.00[CHB][hapmap];0.82[GIH][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap];0.81[AMR][1000 genomes]
rs7503747	0.97[AMR][1000 genomes];0.97[EUR][1000 genomes];0.80[ASN][1000 genomes]
rs8065416	0.85[GIH][hapmap];0.88[MEX][hapmap]
rs8065563	1.00[CHB][hapmap];0.82[GIH][hapmap];0.82[JPT][hapmap];0.91[MEX][hapmap];0.81[AMR][1000 genomes]
rs8066560	1.00[CEU][hapmap];1.00[GIH][hapmap];0.88[MEX][hapmap];0.89[TSI][hapmap];0.98[EUR][1000 genomes]
rs8066982	0.85[GIH][hapmap];0.88[MEX][hapmap]
rs8070128	1.00[CHB][hapmap];0.82[GIH][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap]
rs8070748	0.85[GIH][hapmap];0.88[MEX][hapmap]
rs8073001	0.85[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap]
rs8078105	0.88[MEX][hapmap]
rs8078138	1.00[CHB][hapmap];0.82[GIH][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap]
rs8078583	1.00[CHB][hapmap];0.82[JPT][hapmap]
rs8078756	0.83[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs8079321	0.86[CEU][hapmap];0.88[GIH][hapmap];0.88[MEX][hapmap];0.84[TSI][hapmap];0.86[EUR][1000 genomes]
rs8080061	0.86[CEU][hapmap];0.88[GIH][hapmap];0.88[MEX][hapmap];0.84[TSI][hapmap];0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs8080823	1.00[CHB][hapmap];0.82[GIH][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap]
rs950966	1.00[CHB][hapmap];0.82[GIH][hapmap];0.82[JPT][hapmap];0.87[MEX][hapmap]
rs9891957	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.83[AMR][1000 genomes];0.94[EUR][1000 genomes]
rs9893690	0.91[EUR][1000 genomes]
rs9894257	0.82[AMR][1000 genomes];0.90[EUR][1000 genomes]
rs9895335	0.82[EUR][1000 genomes]
rs9895750	0.83[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs9896837	0.84[MEX][hapmap]
rs9899634	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[MEX][hapmap];0.98[TSI][hapmap];0.91[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs9902941	1.00[CEU][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];0.96[MEX][hapmap];0.98[TSI][hapmap];0.86[AMR][1000 genomes];0.98[EUR][1000 genomes]
rs9906673	0.82[AMR][1000 genomes];0.93[EUR][1000 genomes]
rs9907246	0.86[CEU][hapmap];1.00[CHB][hapmap];0.85[GIH][hapmap];1.00[JPT][hapmap];0.87[MEX][hapmap];0.80[TSI][hapmap];0.83[AMR][1000 genomes];0.85[EUR][1000 genomes]
rs9907287	0.86[CEU][hapmap];0.88[GIH][hapmap];0.88[MEX][hapmap];0.84[TSI][hapmap];0.86[EUR][1000 genomes]
rs9908017	0.83[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs9908299	0.83[AMR][1000 genomes];0.84[EUR][1000 genomes]
rs9911281	0.84[EUR][1000 genomes]
rs9912895	0.85[GIH][hapmap];0.88[MEX][hapmap];0.80[TSI][hapmap]
rs9913277	0.84[MEX][hapmap]
rs9915248	0.95[CEU][hapmap];1.00[CHB][hapmap];0.91[GIH][hapmap];1.00[JPT][hapmap];0.87[MEX][hapmap];0.91[TSI][hapmap];0.82[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs9915776	0.83[AMR][1000 genomes];0.94[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:34 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv907748	chr17:17412032-17782404	Weak transcription Enhancers Genic enhancers Flanking Active TSS Active TSS Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	89 gene(s)	inside rSNPs	diseases
2	nsv1065270	chr17:17430116-17823086	Weak transcription Flanking Active TSS Genic enhancers Enhancers Strong transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	91 gene(s)	inside rSNPs	diseases
3	nsv543236	chr17:17430116-17823086	Bivalent Enhancer Strong transcription Weak transcription Flanking Active TSS Enhancers Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	91 gene(s)	inside rSNPs	diseases
4	nsv907752	chr17:17569012-17750907	Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
5	nsv531183	chr17:17571035-18205309	Genic enhancers Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	123 gene(s)	inside rSNPs	diseases
6	nsv907753	chr17:17573539-17747289	Genic enhancers Enhancers Strong transcription Bivalent Enhancer Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
7	nsv907754	chr17:17573539-17782404	Strong transcription Enhancers Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	78 gene(s)	inside rSNPs	diseases
8	nsv1061126	chr17:17578826-17803194	Strong transcription Genic enhancers Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	80 gene(s)	inside rSNPs	diseases
9	nsv543238	chr17:17578826-17803194	Flanking Active TSS Strong transcription Weak transcription Enhancers Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	80 gene(s)	inside rSNPs	diseases
10	nsv833385	chr17:17594037-17765578	Enhancers Genic enhancers Active TSS Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	75 gene(s)	inside rSNPs	diseases
11	nsv1058884	chr17:17594370-17803194	Enhancers Genic enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
12	nsv543240	chr17:17594370-17803194	Genic enhancers Enhancers Active TSS Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
13	nsv1064176	chr17:17596222-17803194	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
14	nsv543242	chr17:17596222-17803194	Enhancers Active TSS Weak transcription Strong transcription Bivalent Enhancer Genic enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
15	nsv1062361	chr17:17598407-17746899	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA	73 gene(s)	inside rSNPs	diseases
16	nsv543243	chr17:17598407-17746899	Genic enhancers Enhancers Bivalent Enhancer Active TSS Weak transcription Bivalent/Poised TSS Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA	73 gene(s)	inside rSNPs	diseases
17	nsv907756	chr17:17619859-17747289	Enhancers Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Flanking Active TSS Strong transcription Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	71 gene(s)	inside rSNPs	diseases
18	nsv522668	chr17:17619859-17752809	Flanking Active TSS Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	71 gene(s)	inside rSNPs	diseases
19	nsv907757	chr17:17619859-17752809	Flanking Bivalent TSS/Enh Active TSS Strong transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	71 gene(s)	inside rSNPs	diseases
20	nsv907758	chr17:17619859-17782404	Enhancers Weak transcription Flanking Active TSS Genic enhancers Strong transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	72 gene(s)	inside rSNPs	diseases
21	nsv907759	chr17:17619859-17802478	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
22	nsv1059949	chr17:17632590-17803194	Enhancers Genic enhancers Flanking Active TSS Weak transcription Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
23	nsv543244	chr17:17632590-17803194	Weak transcription Flanking Active TSS Active TSS Genic enhancers Enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
24	nsv907760	chr17:17649423-17782404	Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	72 gene(s)	inside rSNPs	diseases
25	nsv907761	chr17:17649423-17802478	Weak transcription Enhancers Active TSS Genic enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
26	nsv916653	chr17:17651916-18454952	Enhancers Strong transcription Active TSS Genic enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	144 gene(s)	inside rSNPs	diseases
27	nsv907762	chr17:17668071-17802478	Weak transcription Genic enhancers Active TSS Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	72 gene(s)	inside rSNPs	diseases
28	nsv907763	chr17:17673824-17749822	Enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	69 gene(s)	inside rSNPs	diseases
29	nsv907764	chr17:17673824-17754633	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Active TSS Genic enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	70 gene(s)	inside rSNPs	diseases
30	nsv907765	chr17:17682484-17802478	Active TSS Strong transcription Enhancers Genic enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	72 gene(s)	inside rSNPs	diseases
31	nsv907766	chr17:17682484-17957348	Enhancers Strong transcription Flanking Active TSS Genic enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	77 gene(s)	inside rSNPs	diseases
32	nsv533142	chr17:17691726-18236686	Active TSS Flanking Active TSS Enhancers Strong transcription Weak transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	116 gene(s)	inside rSNPs	diseases
33	nsv907767	chr17:17709136-17733760	Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Strong transcription Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA	11 gene(s)	inside rSNPs	diseases
34	nsv907768	chr17:17709136-17747289	Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	68 gene(s)	inside rSNPs	diseases

mRNA abundance (count:3)

SNP	Gene	Cis/trans	Tissue	Source
rs11657423	TOM1L2	cis	parietal	SCAN
rs11657423	SREBF1	cis	Whole Blood	GTEx
rs11657423	TOM1L2	cis	cerebellum	SCAN

Chromatin state (count:126 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:17718200-17728600	Transcr. at gene 5' and 3'	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr17:17723200-17730000	Enhancers	Stomach Mucosa	stomach
3	chr17:17723800-17728800	Enhancers	Gastric	stomach
4	chr17:17725000-17729600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
5	chr17:17725600-17728600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr17:17726000-17728800	Enhancers	Placenta Amnion	Placenta Amnion
7	chr17:17726400-17728600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr17:17726800-17729400	Enhancers	Small Intestine	intestine
9	chr17:17726800-17730000	Enhancers	Lung	lung
10	chr17:17726800-17730200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr17:17727000-17729400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr17:17727000-17732200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
13	chr17:17727200-17728600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr17:17727200-17728600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
15	chr17:17727200-17728600	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
16	chr17:17727200-17728600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
17	chr17:17727200-17728600	Flanking Active TSS	Adipose Nuclei	Adipose
18	chr17:17727200-17728600	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
19	chr17:17727200-17728600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
20	chr17:17727200-17728600	Flanking Active TSS	Stomach Smooth Muscle	stomach
21	chr17:17727200-17728600	Flanking Active TSS	A549	lung
22	chr17:17727200-17728600	Flanking Active TSS	HepG2	liver
23	chr17:17727200-17730400	Enhancers	Spleen	Spleen
24	chr17:17727400-17728600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
25	chr17:17727400-17728600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr17:17727400-17728600	Enhancers	Aorta	Aorta
27	chr17:17727400-17728600	Flanking Active TSS	Brain Anterior Caudate	brain
28	chr17:17727400-17728600	Flanking Active TSS	Colon Smooth Muscle	Colon
29	chr17:17727400-17728600	Flanking Active TSS	Rectal Smooth Muscle	rectum
30	chr17:17727400-17728600	Flanking Active TSS	K562	blood
31	chr17:17727400-17729600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
32	chr17:17727400-17729800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
33	chr17:17727600-17728600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
34	chr17:17727600-17728600	Enhancers	H9 Cell Line	embryonic stem cell
35	chr17:17727600-17728600	Enhancers	HUES64 Cell Line	embryonic stem cell
36	chr17:17727600-17728600	Enhancers	iPS-15b Cell Line	embryonic stem cell
37	chr17:17727600-17728600	Enhancers	Brain Angular Gyrus	brain
38	chr17:17727600-17728600	Enhancers	Fetal Brain Female	brain
39	chr17:17727600-17728600	Enhancers	NH-A	brain
40	chr17:17727600-17728800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
41	chr17:17727600-17728800	Enhancers	Primary B cells from peripheral blood	blood
42	chr17:17727600-17728800	Enhancers	Right Atrium	heart
43	chr17:17727600-17729000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
44	chr17:17727600-17729000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
45	chr17:17727600-17729000	Enhancers	HSMM	muscle
46	chr17:17727600-17729400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr17:17727600-17729400	Enhancers	Fetal Stomach	stomach
48	chr17:17727600-17729400	Enhancers	Osteobl	bone
49	chr17:17727600-17729600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr17:17727600-17729600	Enhancers	Muscle Satellite Cultured Cells	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links